Want certainty and predictability in price control mechanism for drugs: OPPI

Image
Press Trust of India New Delhi
Last Updated : Aug 22 2019 | 5:15 PM IST

While pharma industry supports government's initiatives to provide medicines at affordable price to the people, it wants certainty and predictability in the price control mechanism, the Organisation of Pharmaceutical Producers of India (OPPI) said.

The industry body said it aims to make sure that innovative drugs that are available in the rest of the world are made available in India as soon possible.

"The certainty and predictability of price control mechanism is very important for us. What we want is clarity and stable policies so that we can plan and anticipate in advance," OPPI President and Glaxo SmithKline Pharmaceuticals MD India & Vice President South Asia A Vaidheesh told PTI.

OPPI is not against any of the government initiatives to give medicines at affordable prices to the people, he said.

"As a body we also want to understand how to provide medicines at affordable price through healthcare financing mechanism," Vaidheesh said.

He said the industry is evaluating how to participate in Ayushman Bharat to make sure that common men gets access to latest products through the financing schemes, he added.

"We also want that drugs that are already very cheap should not be in the price control mechanism," Vaidheesh said.

He pointed out that it was essential to maintain the quality of generic medicines.

OPPI also announced the launch of a nationwide digital campaign #RefreshingResearch across pharma colleges in the country to highlight the role of science and research in improving patient lives.

Established in 1965, OPPI represents the research-based pharmaceutical companies in India.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 22 2019 | 5:15 PM IST

Next Story